Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii

56Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The interaction between sulbactam and imipenem was evaluated with four clinical isolates of Acinetobacter baumannii, including two isolates resistant to imipenem, one of which produced IMP-1 metallo-β -lactamase. Two isolates (one of which was imipenem-resistant) were sulbactam-resistant by undefined mechanisms. MICs were determined by standard broth microdilution methods. Time-kill assays with imipenem and sulbactam, alone or in combination at 0.5 × MIC and 1 × MIC, showed a synergic effect in all four isolates of A. baumannii after incubation for 0, 4, 8 and > 24 h at 35°C. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Choi, J. Y., Soo Park, Y., Cho, C. H., Seon Park, Y., Shin, S. Y., Song, Y. G., … Kim, J. M. (2004). Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii. Clinical Microbiology and Infection, 10(12), 1098–1101. https://doi.org/10.1111/j.1469-0691.2004.00987.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free